Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

The model has uncovered a hidden layer of molecular code that shapes biological organization, adding new dimensions of ...

AI is increasingly being adopted across healthcare and in 2025, it will be a driving force behind a smarter, nimbler, and ...

His team harnesses advanced computational technologies, including AI, with the aim of enhancing the discovery, design, optimization and synthesis of small molecules to be developed into innovative ...

Insilico Medicine (“Insilico”) announces that the team, with the support of its generative chemistry engine, has developed a ...